Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT02427620 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

131

Enrollment

OTHER

Sponsor class

Conditions

Blastoid Variant Mantle Cell Lymphoma
Mantle Cell Lymphoma
Pleomorphic Variant Mantle Cell Lymphoma

Interventions

DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Doxorubicin
DRUG: Doxorubicin Hydrochloride
DRUG: Ibrutinib
OTHER: Laboratory Biomarker Analysis
DRUG: Methotrexate
BIOLOGICAL: Rituximab
DRUG: Vincristine
DRUG: Vincristine Sulfate

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]